Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRR1 | P24046 | 5/20 | 0.50 |
| ▸ | POLB | P06746 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | APEX1 | P27695 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.46 |
| ▸ | GMNN | O75496 | 1/20 | 0.46 |
| ▸ | TFPI2 | P48307 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.46 |
| ▸ | THPO | P40225 | 1/20 | 0.46 |
| ▸ | SLC1A2 | P43004 | 4/20 | 0.42 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.42 |
| ▸ | GABRR2 | P28476 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | GRM8 | O00222 | 1/20 | 0.39 |
| ▸ | GRM6 | O15303 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9782998 | 0.93 | GABRR1 (0.50) | GABRR1POLBTDP1APEX1KDM4E | |
| SCHEMBL722221 | 0.93 | GABRR1 (0.50) | GABRR1POLBTDP1APEX1KDM4E | |
| Acetic Acid SCHEMBL7138694 | 0.91 | POLB (0.46) | GABRR1POLBTDP1APEX1KDM4E | |
| SCHEMBL8400202 | 0.88 | KDM4E (0.44) | POLBTDP1APEX1KDM4ELMNA | |
| SCHEMBL1297964 | 0.88 | PEPD (0.48) | GABRR1POLBTDP1APEX1KDM4E | |
| SCHEMBL9494071 | 0.88 | GABRR1 (0.46) | GABRR1POLBTDP1APEX1KDM4E | |
| SCHEMBL6864216 | 0.87 | GABRR1 (0.50) | GABRR1POLBTDP1APEX1KDM4E | |
| Hydrochloric Acid SCHEMBL2384923 | 0.84 | GABRR1 (0.48) | GABRR1POLBTDP1APEX1KDM4E | |
| Hydrochloric Acid SCHEMBL2885177 | 0.84 | GABRR1 (0.48) | GABRR1POLBTDP1APEX1KDM4E | |
| SCHEMBL28986143 | 0.83 | GABRR1 (0.42) | GABRR1POLBTDP1APEX1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2398757-A1 | METHOD FOR PRODUCING A FREE ACID FROM THE SALT THEREOF | Evonik Degussa GmbH (DE) | 2011-12-28 | — | — | EP | claimed |
| EP-2398758-A1 | REACTIVE EXTRACTION OF FREE ORGANIC ACIDS FROM AMMONIUM SALTS THEREOF | Evonik Degussa GmbH (DE) | 2011-12-28 | — | — | EP | claimed |
| WO-2010094554-A1 | METHOD FOR PRODUCING A FREE ACID FROM THE SALT THEREOF | EVONIK DEGUSSA GMBH (DE) | 2010-08-26 | — | — | WO | claimed |
| WO-2010094630-A1 | REACTIVE EXTRACTION OF FREE ORGANIC ACIDS FROM AMMONIUM SALTS THEREOF | EVONIK DEGUSSA GMBH (DE) | 2010-08-26 | — | — | WO | claimed |
| US-20100210871-A1 | Reactive Extraction of Free Organic Acids from the Ammonium Salts Thereof | EVONIK DEGUSSA GMBH (DE) | 2010-08-19 | — | — | US | claimed |
| CN-114790270-A | Moisture-curable polyurethane hot-melt resin composition, cured product, and laminate | DIC株式会社 | 2022-07-26 | — | — | CN | disclosed |
| US-9976011-B2 | Polymer composites and fabrications thereof | THE CURATORS OF THE UNIVERSITY OF MISSOURI (US) | 2018-05-22 | — | — | US | disclosed |
| US-20170152347-A1 | AMIDE DENDRIMER COMPOSITIONS | GENZYME CORP (US) | 2017-06-01 | — | — | US | disclosed |
| US-20150321996-A1 | AMIDE DENDRIMER COMPOSITIONS | GENZYME CORPORATION | 2015-11-12 | — | — | US | disclosed |
| US-9066972-B2 | Amide dendrimer compositions | GENZYME CORPORATION (US) | 2015-06-30 | — | — | US | disclosed |
| US-8900560-B2 | Amide dendrimer compositions | GENZYME CORPORATION (US) | 2014-12-02 | — | — | US | disclosed |
| US-20140235724-A1 | AMIDE DENDRIMER COMPOSITIONS | GENZYME CORPORATION (US) | 2014-08-21 | — | — | US | disclosed |
| US-5455325-A | Optically active phenoxypropionic esters | BASF AKTIENGESELLSCHAFT (DE) | 1995-10-03 | — | — | US | disclosed |
| US-5417882-A | Data carriers and display elements | BASF AKTIENGESELLSCHAFT (DE) | 1995-05-23 | — | — | US | disclosed |
| US-5417884-A | Containing a thiadiazole group | BASF AKTIENGESELLSCHAFT (DE) | 1995-05-23 | — | — | US | disclosed |
| EP-0630945-A1 | Use of reticulated azo dyes in non-linear optics | BASF Aktiengesellschaft (DE) | 1994-12-28 | — | — | EP | disclosed |
| US-5350873-A | Optically active phenoxypropionic esters | BASF AKTIENGESELLSCHAFT (DE) | 1994-09-27 | — | — | US | disclosed |
| EP-0583605-A1 | Defined oligomeric liquid crystalline compounds with smectic liquid crystalline phases | BASF Aktiengesellschaft (DE) | 1994-02-23 | — | — | EP | disclosed |
| EP-0528268-A2 | Optically active esters of phenoxypropionic acid | BASF Aktiengesellschaft (DE) | 1993-02-24 | — | — | EP | disclosed |
| EP-0504660-A2 | Liquid crystal compounds | BASF Aktiengesellschaft (DE) | 1992-09-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140235724-A1 | AMIDE DENDRIMER COMPOSITIONS | FABP2, PHOSPHO1, PAM | GABRR1 2167/4885POLB 2395/4885TDP1 3877/4885 |
| US-20100210871-A1 | Reactive Extraction of Free Organic Acids from the Ammonium Salts Thereof | CA2, HCN2, CA9 | GABRR1 3656/4885POLB 2673/4885TDP1 4649/4885 |
| US-20150321996-A1 | AMIDE DENDRIMER COMPOSITIONS | FABP2, PHOSPHO1, PAM | GABRR1 2167/4885POLB 2395/4885TDP1 3877/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.